Drug companies often do one-on-one outreach to doctors. A new study finds these meetings with drug reps lead to more prescriptions for cancer patients, but not longer survival. Chris Hondros/Getty Images hide caption toggle caption Chris Hondros/Getty Images Shots - Health News Oncologists' meetings with drug reps don't help cancer patients live longer April 22, 2024 • Drug company reps commonly visit doctors to talk about new medications. A team of economists wanted to know if that helps patients live longer. They found that for cancer patients, the answer is no. Oncologists' meetings with drug reps don't help cancer patients live longer Listen · 2:11 2:11 Toggle more options Download Embed Embed <iframe src="https://www.npr.org/player/embed/1246054537/1246257369" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Oncologists' meetings with drug reps don't help cancer patients live longer Listen · 2:11 2:11 Toggle more options Download Embed Embed <iframe src="https://www.npr.org/player/embed/1246054537/1246257369" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
